Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas
- PMID: 3282307
- DOI: 10.1126/science.3282307
Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas
Abstract
These studies were set up to determine whether those oncogenes participating in the initiation of mammary carcinogenesis (for example, ras oncogenes) play a direct role in the outcome of events associated with the late stages of tumor development such as loss of hormone dependency. Mammary carcinomas induced by a single carcinogenic insult in pubescent rats was selected as an in vivo model system with direct relevance to human breast cancer. Acquisition of hormone-independent growth in these carcinogen-induced tumors was found to be independent of the activation of ras oncogenes during the early stages of carcinogenesis. In agreement with these observations, introduction of a human ras oncogene into human MCF-7 breast carcinoma cells did not abrogate their hormonal dependency for growth in vivo. These findings suggest that those events responsible for the critical stages of breast cancer development occur independently and in an uncoordinated manner.
Similar articles
-
Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.Jpn J Cancer Res. 2002 Jan;93(1):32-5. doi: 10.1111/j.1349-7006.2002.tb01197.x. Jpn J Cancer Res. 2002. PMID: 11802805 Free PMC article.
-
Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor.Carcinogenesis. 1999 Apr;20(4):677-84. doi: 10.1093/carcin/20.4.677. Carcinogenesis. 1999. PMID: 10223199
-
Activation of ras oncogenes preceding the onset of neoplasia.Science. 1990 Jun 1;248(4959):1101-4. doi: 10.1126/science.2188364. Science. 1990. PMID: 2188364
-
Mechanisms of hormonal prevention of breast cancer.Ann N Y Acad Sci. 2001 Dec;952:23-35. doi: 10.1111/j.1749-6632.2001.tb02725.x. Ann N Y Acad Sci. 2001. PMID: 11795441 Review.
-
A physiological role for estrogen and progesterone in breast cancer.J Steroid Biochem. 1976 Nov-Dec;7(11-12):875-82. doi: 10.1016/0022-4731(76)90005-4. J Steroid Biochem. 1976. PMID: 799735 Review. No abstract available.
Cited by
-
Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.Cancer Metastasis Rev. 1991 Oct;10(3):217-27. doi: 10.1007/BF00050793. Cancer Metastasis Rev. 1991. PMID: 1662559 Review.
-
William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.Breast Cancer Res Treat. 1993;27(1-2):27-40. doi: 10.1007/BF00683191. Breast Cancer Res Treat. 1993. PMID: 7505127 Review.
-
The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.EMBO J. 1989 Mar;8(3):823-9. doi: 10.1002/j.1460-2075.1989.tb03443.x. EMBO J. 1989. PMID: 2498085 Free PMC article.
-
Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.Jpn J Cancer Res. 2002 Jan;93(1):32-5. doi: 10.1111/j.1349-7006.2002.tb01197.x. Jpn J Cancer Res. 2002. PMID: 11802805 Free PMC article.
-
Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.Mol Cell Biol. 1993 Mar;13(3):1759-68. doi: 10.1128/mcb.13.3.1759-1768.1993. Mol Cell Biol. 1993. PMID: 8441411 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical